Combining dimensional and categorical representation of psychosis: The way forward for DSM-V and ICD-11?

Psychological Medicine

Volumn 39, Issue 12, 2009, Pages 1943-1955

  Demjaha, A ^a   Morgan, K ^b   Morgan, C ^a   Landau, S ^a   Dean, K ^a   Reichenberg, A ^a   Sham, P ^c   Fearon, P ^a   Hutchinson, G ^d   Jones, P B ^e   Murray, R M ^a   Dazzan, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WESTMINSTER   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF THE WEST INDIES   (Jamaica)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Diagnostic categories; Dimensions; Factor analysis; First episode psychosis; Risk indicators

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DISORIENTATION; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; POPULATION RESEARCH; PSYCHOSIS; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; INCIDENCE; INTELLIGENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MARIJUANA ABUSE; MIDDLE AGED; PATIENT ADMISSION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOPATHOLOGY; PSYCHOTIC DISORDERS; RISK FACTORS; SOCIAL BEHAVIOR; YOUNG ADULT;

EID: 70449678722     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709990651     Document Type: Article

References (67)

1. Allardyce J, McCreadie GR, Morrison G, Van Os J (2007). Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis? Social Psychiatry and Psychiatric Epidemiology 42, 429-437.
2. Andreasen NC, Olsen S (1982). Negative v. positive schizophrenia: definition and validation. Archives of General Psychiatry 39, 789-794.
3. Arango C, Kirkpatrick B, Buchanan RW (2000). Neurological signs and the heterogeneity of schizophrenia. American Journal of Psychiatry 157, 560-565.
4. Arndt S, Alliger RJ, Andreasen NC (1991). The distinction of positive and negative symptoms. The failure of a two-dimensional model. British Journal of Psychiatry 158, 317-322.
5. Bilder RM, Mukherjee S, Reider RO, Panduragi AK (1985). Symptomatic and neuropsychological components of defect states. Schizophrenia Bulletin 11, 409-419.
6. Boks MP, Liddle PF, Burgerhof JGM, Knegtering R, Van den Bosch RJ (2004). Neurological soft signs discriminating mood disorders from first episode schizophrenia. Acta Psychiatrica Scandinavica 110, 29-35.
7. Brown KW, White T (1992). Syndromes of chronic schizophrenia and some clinical correlates. British Journal of Psychiatry 161, 317-322.
8. Buchanan RW, Heinrichs DW (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 27, 335-350.
9. Crow TJ (1980). Molecular pathology of schizophrenia: more than one disease process? British Medical Journal 280, 66-68.
10. Cardno AG, Sham PC, Murray RM, McGuffin P (2001). Twin study of symptom dimensions in psychoses. British Journal of Psychiatry 179, 39-45.
11. Comrey AL, Lee HB (1992). A First Course in Factor Analysis, 2nd edn. Lawrence Erlbaum Associates: Hillsdale, NJ.
12. Costello AB, Osborne JW (2005). Best practices in exploratory factor analysis: Four recommendations for getting the most from your analysis. Practical Assessment, Research & Evaluation 10, 1-9.
13. Cuesta MJ, Peralta V, Gil P, Artamendi M (2003). Psychopathological dimensions in first-episode psychoses. From the trunk to the branches and leaves. European Archives of Psychiatry and Clinical Neuroscience 253, 73-79.
14. Dazzan P, Morgan KD, Orr KG, Hutchinson G, Xavier Chitnis C, Suckling J, Fearon P, Salvo J, McGuire PK, Mallett RM, Jones PB, Leff J, Murray RM (2004). The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 127, 143-153.
15. Dazzan P, Morgan K, Chitnis X, Suckling J, Morgan C, Fearon P, McGuire PK, Jones P, Leff J, Murray RM (2006). The structural brain correlates of neurological soft signs in healthy individuals. Cerebral Cortex 16, 1225-1231.
16. Dikeos DG, Wickham H, McDonald C, Walshe M, Sigmundsson TH, Bramon E, Grech A, Toulopoulou T, Murray R, Sham P (2006). Distribution of symptom dimensions across Kraepelinian divisions. British Journal of Psychiatry 189, 346-353.
17. Drake RJ, Dunn G, Tarrier N, Haddock G, Haley C, Lewis S (2003). The evolution of symptoms in the early course of non-affective psychosis. Schizophrenia Research 63, 171-179.
18. Edwards J, McGorry PD, Wadell FM, Harrigan SM (1999). Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophrenia Research 40, 147-158.
19. Emsley RA, Oosthuizen P, Joubert A, Roberts MC, Stein DJ (1999). Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. Journal of Clinical Psychiatry 60, 747-751.
20. Fearon P, Kirkbride JK, Morgan C, Dazzan P, Morgan K, Lloyd T, Hutchinson G, Tarrant J, Fung A, Holloway J, Mallett R, Harrison G, Leff J, Jones PB, Murray RM (2006). Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study. Psychological Medicine 36, 1541-1550.
21. Fenton WS, McGlashan TH (1991). Natural history of schizophrenia subtypes: II. Positive and negative symptoms and long-term course. Archives of General Psychiatry 48, 978-986.
22. Grube BS, Bilder RM, Goldman RS (1998). Meta-analysis of symptom factors in schizophrenia. Schizophrenia Research 31, 113-120.
23. Guerra A, Fearon P, Sham P, Jones P, Lewis S, Mata I, Murray R (2002). The relationship between predisposing factors, premorbid function and symptom dimensions in psychosis: an integrated approach. European Psychiatry 17, 311-320.
24. Harris MG, Henry LP, Harrigan SM, Purcell R, Schwartz OS, Farrelly SE, Prosser AL, Jackson HJ, McGorry PD (2005). The relationship between duration of untreated psychosis and outcome: an eight-year prospective study. Schizophrenia Research 79, 85-93.
25. Harrison G, Croudace T, Mason P, Glazebrook C, Medley I (1996). Predicting long-term outcome in schizophrenia. Psychological Medicine 26, 697-705.
26. Hutchinson G, Takei N, Sham P, Harvey I, Murray RM (1999). Factor analysis of symptoms in schizophrenia: differences between white and Caribbean patients in Camberwell. Psychological Medicine 29, 607-612.
27. Jablensky A, Kendell RE (2002). Criteria for assessing a classification in psychiatry. In The Future of Psychiatric Diagnosis and Classification (ed. M Maj, W Gaebel, J López-Ibor and N. Sartorius), pp. 1-24. Wiley: Chichester.
28. Kay SR, Fiszbein A, Opler LA (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13, 261-275.
29. Kitamura T, Okazaki Y, Fujinawa A, Takayanagi I, Kasahara Y (1995). Symptoms of psychosis. A factor-analytic study. British Journal of Psychiatry 166, 236-240.
30. Lane A, Kinsella A, Murphy P, Byrne M, Keenan J, Colgan K, Cassidy B, Sheppard N, Horgan R, Waddington JL, Larkin C, O'Callaghan E (1997). The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychological Medicine 27, 1155-1164.
31. Larsen TK, Moe LC, Vibe-Hansen L, Johannessen JO (2000). Premorbid functioning versus duration of untreated psychosis in 1 year outcome in first-episode psychosis. Schizophrenia Research 45, 1-9.
32. Liddle PF (1987). The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. British Journal of Psychiatry 151, 145-151.
33. Liddle PF, Barnes TR (1990). Syndromes of chronic schizophrenia. British Journal of Psychiatry 157, 558-561.
34. Liddle PF, Ngan ETN, Duffield G, Kho K, Warren AJ (2002). The signs and symptoms of psychotic illness: a rating scale. British Journal of Psychiatry 180, 45-50.
35. Lindenmayer JP, Grochowski S, Hyman RB (1995). Five factor model of schizophrenia: replication across samples. Schizophrenia Research 14, 229-234.
36. Malla A, Payne J (2005). First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophrenia Bulletin 31, 650-671.
37. Malla AK, Norman RMG, Manchanda R, Ahmed MR, Scholten D, Harricharan R, Cortese L, Takhar J (2002). One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophrenia Research 54, 231-242.
38. Malla AK, Norman RMG, Williamson PWC, Cortese L, Diaz F (1993). Three syndrome concept of schizophrenia: a factor analytic study. Schizophrenia Research 10, 143-150.
39. McGlashan TH, Fenton WS (1993). Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin 19, 71-84.
40. McGorry P, Bell RC, Dudgeon PL, Jackson HJ (1998). The dimensional structure of first episode psychosis: an exploratory factor analysis. Psychological Medicine 28, 935-947.
41. McIntosh AM, Forrester A, Lawrie SM, Byrne M, Harper A, Kestelman JN, Best K, Miller P, Johnstone EC, Owens DGC (2001). A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology. Psychological Medicine 31, 159-171.
42. Mellers JDC, Sham P, Jones PB, Toone BK, Murray RM (1996). A factor analytic study of symptoms in acute schizophrenia. Acta Psychiatrica Scandinavica 93, 92-98.
43. Morgan C, Fearon P, Hutchinson G, Mckenzie K, Lappin JM, Abdul AR, Morgan K, Dazzan P, Boydell J, Harrison G, Craig T, Leff J, Jones P, Murray RM (2006). Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study. Psychological Medicine 36, 239-247.
44. Murray RM, Lewis SW (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal 295, 681-682.
45. Nelson HE, Willison JR (1991). The Revised National Adult Reading Test-Test Manual. NFER-Nelson: Windsor.
46. Norman R, Malla AK, Morrison-Stewart SL, Helmes E, Williamson PC, Thomas J, Cortese L (1997). Neuropsychological correlates of syndromes in schizophrenia. British Journal of Psychiatry 170, 134-139.
47. O'Callaghan E, Buckley P, Madigan C, Redmond O, Stack P, Kinsella A, Larkin C, Ennis JT, Waddington JL (1995). The relationship of minor physical anomalies and other putative indices of developmental disturbance in schizophrenia to abnormalities of cerebral structure on magnetic resonance imaging. Biological Psychiatry 38, 516-524.
48. Peralta V, Cuesta MJ (2001). How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophrenia Research 49, 269-285.
49. Peralta V, Cuesta MJ, De Leon J (1994). An empirical analysis of latent structures underlying schizophrenic symptoms: a four syndrome model. Biological Psychiatry 36, 726-736.
50. Peralta V, Cuesta MJ, Giraldo C, Cardenas A, Gonzalez F (2002). Classifying psychotic disorders: issues regarding categorical vs. dimensional approaches and time frame to assess symptoms. European Archives in Psychiatry and Clinical Neuroscience 252, 12-18.
51. Peralta V, De Leon J, Cuesta MJ (1992). Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. British Journal of Psychiatry 161, 335-343.
52. Rietkerk T, Boks MP, Sommer IE, Liddle PF, Ophoff RA, Kahn RS (2008). The genetics of symptom dimensions of schizophrenia: review and meta-analysis. Schizophrenia Research 102, 197-205.
53. Rosenman S, Korten A, Medway J, Evans M (2003). Dimensional vs. categorical diagnosis in psychosis. Acta Psychiatrica Scandinavica 107, 378-384.
54. Rotakonda S, Gorman JM, Yale SA, Amador XF (1998). Characterization of psychotic conditions. Use of the domains of psychopathology model. Archives of General Psychiatry 55, 75-81.
55. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Feiner D, Rotrosen J, Wolkin A (2000). Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Archives of General Psychiatry 57, 471-480.
56. Silver H, David D, Kaplan M, Hadjez J, Tubi N, Darnel A, Calev A, Lerer B (1993). Factor analysis of schizophrenic symptoms and comparison of different ratings scales. Schizophrenia Research 10, 67-75.
57. Smith DA, Mar CM, Turoff BK (1998). The structure of schizophrenic symptoms: a meta-analytic confirmatory factor analysis. Schizophrenia Research 31, 57-70.
58. Tabachnick BG, Fidell LS (1989). Using Multivariate Statistics, 2nd edn. Harper Collins: New York.
59. York der Gaag M, Cuijpers A, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, van Harten PN, Valmaggia L, de Hert M, Wiersma D (2006a). The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophrenia Research 85, 273-279.
60. Van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, van Harten PN, Valmaggia L, de Hert M, Cuijpers A, Wiersma D (2006b). The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophrenia Research 85, 280-287.
61. Van Os J, Fahy TA, Jones P, Harvey I, Sham P, Lewis S, Bebbington P, Toone B, Williams M, Murray R (1996). Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychological Medicine 26, 161-176. (Pubitemid 26031812)
62. Van Os J, Gilvarry C, Bale R, Van Horn E, Tattan T, White I, Murray R (1999). A comparison of the utility of dimensional and categorical representations of psychosis. UK700 Group. Psychological Medicine 29, 595-606.
63. Van Os J, Marcelis M, Sham P, Jones P, Gilvary K, Murray R (1997). Psychopathological syndromes and familial morbid risk of psychosis. British Journal of Psychiatry 170, 241-246.
64. Van Os J, Verdoux H (2003). Diagnosis and classification in schizophrenia: categories versus dimensions, distributions versus disease. In The Epidemiology of Schizophrenia (ed. R. M. Murray, P. B. Jones, E. Susser, J. van Os and M. Cannon), pp. 364-410. Cambridge University Press: Cambridge.
65. Cambridge University Press: Cambridge. Wickham H, Walsh C, Asherson P, Taylor C, Sigmundson T, Gill M, Owen MJ, McGuffin P, Murray R, Sham P (2001). Familiality of symptom dimensions in schizophrenia. Schizophrenia Research 47, 223-232.
66. Wong AH, Voruganti LN, Heslegrave RJ, Awad AG (1997). Neurocognitive deficits and neurological signs in schizophrenia. Schizophrenia Research 23, 139-146.
67. WHO (1992). SCAN (Schedules for Clinical Assessment in Neuropsychiatry). World Health Organization: Geneva.